CD8A and head and neck squamous cell carcinoma: Conversely, the inhibitory receptor NKG2A, known to be expressed on intratumoral CD8+ CD103+ effector T cells and linked to progression in head and-neck squamous cell carcinoma patients22, was more prominent in the CD127+ CD39lo Trm subpopulation (Fig. 2b).